Product Information
NATEGLINIDE 120 MG TABLET is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.2411 per EA under NDC 55111032990. Its NADAC has been published 658 times since Nov 28, 2013.
FDA first approved this application on Sep 9, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the Nateglinide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
120 mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
55111032990
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
6/17/2026
Active Ingredients
NATEGLINIDEApproval Type
Generic (ANDA)
FDA Application
ANDA077461FDA Approved
9/9/2009
TE Code
AB
On Market Since
9/9/2009
Pharmacological Classes
Price Statistics
The NADAC for NATEGLINIDE 120 MG TABLET has been published 658 times since Nov 28, 2013, and over the history we have for it it has declined 66.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2411 per EA |
|---|---|
| All-time high | $0.7584 (Aug 13, 2014) |
| All-time low | $0.2154 (Nov 22, 2023) |
| 52-week high | $0.2609 |
| 52-week low | $0.2411 |
| Median price | $0.4031 |
| Average price | $0.4474 |
| Largest weekly change | -30.0% (Nov 22, 2023) |
| Weeks tracked | 658 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
-0.3%
6M
-6.1%
1Y
-2.5%
3Y
-18.9%
5Y
-28.3%
All
-66.7%
Last surveyed Jul 1, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of NATEGLINIDE 120 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for NATEGLINIDE 120 MG TABLET, manufactured by Dr. Reddy's Laboratories Inc., is $0.2411 per EA (NDC 55111032990), effective Jul 1, 2026.
How has the price of NATEGLINIDE 120 MG TABLET changed over time?
Over the history we have for it, the NADAC for NATEGLINIDE 120 MG TABLET has declined 66.7%. It has been tracked across 658 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NATEGLINIDE 120 MG TABLET?
Since Nov 28, 2013, the NADAC for NATEGLINIDE 120 MG TABLET has ranged from a low of $0.2154 (Nov 22, 2023) to a high of $0.7584 (Aug 13, 2014), with a median of $0.4031 per EA.
Are there cheaper alternatives to NATEGLINIDE 120 MG TABLET?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NATEGLINIDE 120 MG TABLET, is $0.2345 per EA — about 3% below NATEGLINIDE 120 MG TABLET.
Who manufactures NATEGLINIDE 120 MG TABLET?
NATEGLINIDE 120 MG TABLET (NDC 55111032990) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.